Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $231000.0.

  • Amphastar Pharmaceuticals' Other Non Operating Income rose 10453.47% to $231000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 15643.79%. This contributed to the annual value of $4.1 million for FY2024, which is 20374.14% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Other Non Operating Income stood at $231000.0, which was up 10453.47% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income registered a high of $13.3 million during Q3 2021, and its lowest value of -$5.5 million during Q4 2023.
  • In the last 5 years, Amphastar Pharmaceuticals' Other Non Operating Income had a median value of $298000.0 in 2024 and averaged $1.2 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Other Non Operating Income plummeted by 26238.15% in 2023, and later skyrocketed by 161820.51% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income (Quarter) stood at $2.9 million in 2021, then rose by 15.58% to $3.4 million in 2022, then tumbled by 262.38% to -$5.5 million in 2023, then soared by 153.83% to $3.0 million in 2024, then tumbled by 92.17% to $231000.0 in 2025.
  • Its last three reported values are $231000.0 in Q3 2025, $1.5 million for Q2 2025, and -$2.2 million during Q1 2025.